FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3011359096> ?p ?o ?g. }

• W3011359096 endingPage "471" @default.
• W3011359096 startingPage "471" @default.
• W3011359096 abstract "Overexpression of G protein-coupled receptors (GPCRs) in tumours is widely used to develop GPCR-targeting radioligands for solid tumour imaging in the context of diagnosis and even treatment. The human vasoactive neuropeptide urotensin II (hUII), which shares structural analogies with somatostatin, interacts with a single high affinity GPCR named UT. High expression of UT has been reported in several types of human solid tumours from lung, gut, prostate, or breast, suggesting that UT is a valuable novel target to design radiolabelled hUII analogues for cancer diagnosis. In this study, two original urotensinergic analogues were first conjugated to a DOTA chelator via an aminohexanoic acid (Ahx) hydrocarbon linker and then -hUII and DOTA-urantide, complexed to the radioactive metal indium isotope to successfully lead to radiolabelled DOTA-Ahx-hUII and DOTA-Ahx-urantide. The 111In-DOTA-hUII in human plasma revealed that only 30% of the radioligand was degraded after a 3-h period. DOTA-hUII and DOTA-urantide exhibited similar binding affinities as native peptides and relayed calcium mobilization in HEK293 cells expressing recombinant human UT. DOTA-hUII, not DOTA-urantide, was able to promote UT internalization in UT-expressing HEK293 cells, thus indicating that radiolabelled 111In-DOTA-hUII would allow sufficient retention of radioactivity within tumour cells or radiolabelled DOTA-urantide may lead to a persistent binding on UT at the plasma membrane. The potential of these radioligands as candidates to target UT was investigated in adenocarcinoma. We showed that hUII stimulated the migration and proliferation of both human lung A549 and colorectal DLD-1 adenocarcinoma cell lines endogenously expressing UT. In vivo intravenous injection of 111In-DOTA-hUII in C57BL/6 mice revealed modest organ signals, with important retention in kidney. 111In-DOTA-hUII or 111In-DOTA-urantide were also injected in nude mice bearing heterotopic xenografts of lung A549 cells or colorectal DLD-1 cells both expressing UT. The observed significant renal uptake and low tumour/muscle ratio (around 2.5) suggest fast tracer clearance from the organism. Together, DOTA-hUII and DOTA-urantide were successfully radiolabelled with 111Indium, the first one functioning as a UT agonist and the second one as a UT-biased ligand/antagonist. To allow tumour-specific targeting and prolong body distribution in preclinical models bearing some solid tumours, these radiolabelled urotensinergic analogues should be optimized for being used as potential molecular tools for diagnosis imaging or even treatment tools." @default.
• W3011359096 created "2020-03-23" @default.
• W3011359096 creator A5002386951 @default.
• W3011359096 creator A5003635559 @default.
• W3011359096 creator A5013065512 @default.
• W3011359096 creator A5020539519 @default.
• W3011359096 creator A5025524404 @default.
• W3011359096 creator A5027818597 @default.
• W3011359096 creator A5034569915 @default.
• W3011359096 creator A5048105705 @default.
• W3011359096 creator A5057930059 @default.
• W3011359096 creator A5075307650 @default.
• W3011359096 creator A5076243631 @default.
• W3011359096 creator A5080464170 @default.
• W3011359096 creator A5091229393 @default.
• W3011359096 date "2020-03-19" @default.
• W3011359096 modified "2023-10-05" @default.
• W3011359096 title "Development of Novel 111-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours" @default.
• W3011359096 cites W1831866287 @default.
• W3011359096 cites W1862826322 @default.
• W3011359096 cites W1935825021 @default.
• W3011359096 cites W1963688331 @default.
• W3011359096 cites W1967417567 @default.
• W3011359096 cites W1970447441 @default.
• W3011359096 cites W1971952688 @default.
• W3011359096 cites W1977784339 @default.
• W3011359096 cites W1982243031 @default.
• W3011359096 cites W1982962635 @default.
• W3011359096 cites W1983169511 @default.
• W3011359096 cites W1985249499 @default.
• W3011359096 cites W1991326521 @default.
• W3011359096 cites W1999922935 @default.
• W3011359096 cites W2005674134 @default.
• W3011359096 cites W2009629472 @default.
• W3011359096 cites W2013004232 @default.
• W3011359096 cites W2015548817 @default.
• W3011359096 cites W2018848884 @default.
• W3011359096 cites W2024109581 @default.
• W3011359096 cites W2027676394 @default.
• W3011359096 cites W2037725619 @default.
• W3011359096 cites W2038809664 @default.
• W3011359096 cites W2040151972 @default.
• W3011359096 cites W2041513939 @default.
• W3011359096 cites W2045681528 @default.
• W3011359096 cites W2047223322 @default.
• W3011359096 cites W2051335792 @default.
• W3011359096 cites W2054655872 @default.
• W3011359096 cites W2057064048 @default.
• W3011359096 cites W2058127740 @default.
• W3011359096 cites W2065256681 @default.
• W3011359096 cites W2075075102 @default.
• W3011359096 cites W2079475292 @default.
• W3011359096 cites W2084029889 @default.
• W3011359096 cites W2087136719 @default.
• W3011359096 cites W2089636789 @default.
• W3011359096 cites W2095553751 @default.
• W3011359096 cites W2098715716 @default.
• W3011359096 cites W2099478219 @default.
• W3011359096 cites W2101718405 @default.
• W3011359096 cites W2105453486 @default.
• W3011359096 cites W2113106035 @default.
• W3011359096 cites W2114315732 @default.
• W3011359096 cites W2117157173 @default.
• W3011359096 cites W2117662997 @default.
• W3011359096 cites W2125398839 @default.
• W3011359096 cites W2127887554 @default.
• W3011359096 cites W2138864190 @default.
• W3011359096 cites W2141196290 @default.
• W3011359096 cites W2142892314 @default.
• W3011359096 cites W2148617171 @default.
• W3011359096 cites W2164765814 @default.
• W3011359096 cites W2170033391 @default.
• W3011359096 cites W2175610922 @default.
• W3011359096 cites W2179747970 @default.
• W3011359096 cites W2196195149 @default.
• W3011359096 cites W2213860079 @default.
• W3011359096 cites W2237644705 @default.
• W3011359096 cites W2280882155 @default.
• W3011359096 cites W2315593632 @default.
• W3011359096 cites W2316137824 @default.
• W3011359096 cites W2321745733 @default.
• W3011359096 cites W2339037925 @default.
• W3011359096 cites W2472496872 @default.
• W3011359096 cites W2500267155 @default.
• W3011359096 cites W2516568534 @default.
• W3011359096 cites W2529464764 @default.
• W3011359096 cites W2530465219 @default.
• W3011359096 cites W2535256609 @default.
• W3011359096 cites W2552627117 @default.
• W3011359096 cites W2560788489 @default.
• W3011359096 cites W2560994126 @default.
• W3011359096 cites W2592773334 @default.
• W3011359096 cites W2602727071 @default.
• W3011359096 cites W2607636539 @default.
• W3011359096 cites W2610882330 @default.
• W3011359096 cites W2726337184 @default.
• W3011359096 cites W2750074602 @default.
• W3011359096 cites W2765153686 @default.

• next